Ester Aparicio Prats

Long-lasting antibody B-cell responses to SARS-CoV-2 three years after the onset of the pandemic.

Impact of Dolutegravir plus Lamivudine as First-Line Antiretroviral Treatment on HIV-1 Reservoir and Inflammatory Markers in Peripheral Blood.

Natural prevalence of HCV minority variants that are highly resistant to NS3/4A protease inhibitors.

IL28B SNP rs8099917 is strongly associated with pegylated interferon-α and ribavirin therapy treatment failure in HCV/HIV-1 coinfected patients.

Rapid spread and genetic diversification of HIV type 1 subtype C in a rural area of southern Mozambique.